2022-08-20 高雄萬豪酒店 10F皇喜會議室 10D-1
時間主題講者座長摘要簡報
10:30 ~ 10:40
PD02-1: Mir-299-3p inhibits cell proliferation, motility and invasion through VEGFA in upper tract urothelial carcinoma
王建勝
蔡曜州,
鍾旭東
10:40 ~ 10:50
PD02-2: The prognostic significance of ROR2 expression in patients with urothelial carcinoma
李威明
蔡曜州,
鍾旭東
10:50 ~ 11:00
PD02-3: Decreased Dehydrogenase/Reductase 2(DHRS2) expression is associated with poor prognosis in urothelial carcinoma patients
吳奕儒
蔡曜州,
鍾旭東
11:00 ~ 11:10
PD02-4: Outcomes of chemotherapy agents as subsequent replacements for discontinued Bacillus Calmette-Guerin bladder instillation in bladder cancer
林柏廷
蔡曜州,
鍾旭東
11:10 ~ 11:20
PD02-5: Predictive factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
陳震亞
蔡曜州,
鍾旭東
11:20 ~ 11:30
PD02-6: The therapeutic potential of chemoradiotherapy combine with regional hyperthermia therapy for locally advanced bladder cancer- phase III clinical trial preliminary data report
王大齊
蔡曜州,
鍾旭東